Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Richard M Bergenstal, MD
International Diabetes Center at Park Nicollet
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
52 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hopital Avicenne
Bobigny, France
- Hopital Saint-Andre
Bordeaux, France
- Hopital Hotel-Dieu Site Harfleur
Le Creusot, France
- Lapeyronie Hospital, University Hospital Montpellier
Montpellier, France
- Hopital Lariboisiere, Centre Universitaire Du Diabete Et de Ses Complications
Paris, France
- Chu de Nantes-Hospital Nord Laennec
Saint-Herblain, France
- Ghmp Les Portes Du Sud
Vénissieux, France
- Diabeteszentrum Do-Diabetologisch
Dortmund, Germany
- Bag Unterm Heilig Kreuz Unterm Heilig Kreuz
Fulda, Germany
- Diabetes Zentrum Und Praxis Prof. Pfutzner Parcusstr.
Mainz, Germany
- Royal United Hospital, Diabetes & Lipid Research Wolfson Centre
Bath, United Kingdom
- Royal Blackburn Hospital, East Lancashire Hospitals Nhs Trust
Blackburn, United Kingdom
- Chorley and South Ribble Hospital
Chorley, United Kingdom
- Ninewells Hospital & Medical School Diabetes Support Unit
Dundee, United Kingdom
- Forth Valley Royal Hospital Dept. of Diabetes
Larbert, United Kingdom
- Leicester General Hospital Leicester Diabetes Centre
Leicester, United Kingdom
- Royal Liverpool University Hospital
Liverpool, United Kingdom
- Central Phoenix Medical Clinic
Phoenix, Arizona, United States
- Advanced Metabolic Care & Research Institute, Inc. (amcr)
Escondido, California, United States
- Marin Endocrine Care and Research
Greenbrae, California, United States
- National Research Institute - Wilshire
Los Angeles, California, United States
- Diabetes Research Institute Mills-Peninsula Health Service
San Mateo, California, United States
- Encompass Clinical Research
Spring Valley, California, United States
- Denver Va Medical Center
Denver, Colorado, United States
- Atlanta Diabetes Associates
Atlanta, Georgia, United States
- Columbus Regional Research Institute
Columbus, Georgia, United States
- Physicians Research Associates
Lawrenceville, Georgia, United States
- Endocrine Research Solutions, Inc
Roswell, Georgia, United States
- Rocky Mountain Diabetes and Osteoporosis Center Pa
Idaho Falls, Idaho, United States
- John H. Stroger, Jr. Hospital of Cook County Diabetes Center
Chicago, Illinois, United States
- Northwestern University the Feinberg School of Medicine
Chicago, Illinois, United States
- Iowa Diabetes and Endocrinology Research Center
Des Moines, Iowa, United States
- Cotton-O'Neil Clinical Research Center
Topeka, Kansas, United States
- Great Plains Diabetes
Wichita, Kansas, United States
- Kentucky Diabetes Endocrinology Center
Lexington, Kentucky, United States
- Medstar Health Research Institute
Hyattsville, Maryland, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Park Nicollet Institute International Diabetes Center
Minneapolis, Minnesota, United States
- Suny Upstate Medical University
Syracuse, New York, United States
- Va Medical Center Cleveland
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Aug 2015
- Primary completion
- 31 Aug 2017
- Completion
- 31 Aug 2017
- Last update posted
- 4 Feb 2025
- Registered enrollment
- 278
- Registry id
- NCT02542631
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.